SSY Group Limited (2005.HK)

HKD 2.98

(1.02%)

Net Debt Summary of SSY Group Limited

  • SSY Group Limited's latest annual net debt in 2023 was 1.71 Billion HKD , up 14.4% from previous year.
  • SSY Group Limited's latest quarterly net debt in 2024 Q2 was 2.04 Billion HKD , down 0.0% from previous quarter.
  • SSY Group Limited reported annual net debt of 1.49 Billion HKD in 2022, up 6.0% from previous year.
  • SSY Group Limited reported annual net debt of 1.41 Billion HKD in 2021, up 43.51% from previous year.
  • SSY Group Limited reported quarterly net debt of 1.71 Billion HKD for 2023 FY, up 14.4% from previous quarter.
  • SSY Group Limited reported quarterly net debt of 1.71 Billion HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Net Debt Chart of SSY Group Limited (2023 - 2004)

Historical Annual Net Debt of SSY Group Limited (2023 - 2004)

Year Net Debt Net Debt Growth
2023 1.71 Billion HKD 14.4%
2022 1.49 Billion HKD 6.0%
2021 1.41 Billion HKD 43.51%
2020 984.61 Million HKD 12.3%
2019 876.81 Million HKD 48.0%
2018 592.44 Million HKD -44.18%
2017 1.06 Billion HKD -5.3%
2016 1.12 Billion HKD -23.97%
2015 1.47 Billion HKD 169.64%
2014 546.7 Million HKD -35.75%
2013 850.86 Million HKD 104.18%
2012 416.72 Million HKD 162.69%
2011 158.63 Million HKD 195.7%
2010 -165.76 Million HKD -54.02%
2009 -107.62 Million HKD -121.39%
2008 503.08 Million HKD 17.04%
2007 429.82 Million HKD 687.89%
2006 54.55 Million HKD 139.0%
2005 -139.88 Million HKD -1190.37%
2004 12.82 Million HKD 0.0%

Peer Net Debt Comparison of SSY Group Limited

Name Net Debt Net Debt Difference
Pak Fah Yeow International Limited -258.7 Million HKD 762.351%
Grand Pharmaceutical Group Limited 2.03 Billion HKD 15.667%
Extrawell Pharmaceutical Holdings Limited 5.94 Million HKD -28727.776%
Wai Yuen Tong Medicine Holdings Limited 301.53 Million HKD -468.265%
Qianhai Health Holdings Limited -19.03 Million HKD 9100.541%
Lee's Pharmaceutical Holdings Limited 30.94 Million HKD -5436.781%
Essex Bio-Technology Limited -219.22 Million HKD 881.613%
Tongfang Kontafarma Holdings Limited 256.16 Million HKD -568.916%
PuraPharm Corporation Limited 377.54 Million HKD -353.854%
JBM (Healthcare) Limited -7.39 Million HKD 23258.846%
Jacobson Pharma Corporation Limited 337.44 Million HKD -407.798%
China Resources Pharmaceutical Group Limited 50.97 Billion HKD 96.639%